Sign in
Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group
Journal article   Peer reviewed

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group

Dennis M Black, Steven R Cummings, David B Karpf, Jane A Cauley, Desmond E Thompson, Michael C Nevitt, Douglas C Bauer, Harry K Genant, William L Haskell, Robert Marcus, …
The Lancet (British edition), Vol.348(9041), pp.1535-1541
12/07/1996
DOI: 10.1016/s0140-6736(96)07088-2
PMID: 8950879

View Online

Abstract

Previous studies have shown that alendronate can increase bone mineral density (BMD) and prevent radiographically defined (morphometric) vertebral fractures. The Fracture Intervention Trial aimed to investigate the effect of alendronate on the risk of morphometric as well as clinically evident fractures in postmenopausal women with low bone mass.
Radiography Follow-Up Studies Humans Middle Aged Risk Osteoporosis, Postmenopausal - drug therapy Alendronate - therapeutic use Spinal Fractures - diagnostic imaging Femur Neck - diagnostic imaging Spinal Fractures - prevention & control Alendronate - adverse effects Bone Density - drug effects Hip Fractures - prevention & control Spinal Fractures - complications Aged, 80 and over Hip Fractures - diagnostic imaging Female Aged Fractures, Bone - diagnostic imaging Femur Neck - drug effects Fractures, Bone - prevention & control Alendronate - administration & dosage

Details

Logo image